Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OPTOPOL Technology is a Polish ophthalmic diagnostics company that designs, manufactures, and sells imaging and visual field testing systems for eye care professionals. The company is best known for its spectral-domain optical coherence tomography (SD-OCT) platforms and automated perimeters used for diagnosis and monitoring of retinal, glaucoma, optic nerve, and anterior segment conditions. OPTOPOL states that it was the first company to commercialize spectral-domain OCT and today markets a portfolio including the REVO OCT family and PTS perimetry systems. The business operates in more than 100 countries through direct operations and distributors, with headquarters, manufacturing, research, and training centered in Zawiercie, Poland. It also maintains a U.S. subsidiary and has recently expanded local commercial presence in Australia and New Zealand.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OPTOPOL Technology.